GlossaryMechanismAngiogenesis
Mechanism

Angiogenesis

Also known as: neovascularization · new blood vessel formation

Angiogenesis is the growth of new blood vessels from existing ones, a normal part of development and wound repair that tumors can also exploit.

Blood vessels are the first organ to form in the embryo and make up the largest network in the body. Angiogenesis is the sprouting of new capillaries from vessels that already exist, driven by growth signals such as VEGF acting on its receptors, including VEGFR2. Healing tissue needs that new blood supply to bring oxygen, nutrients and immune cells into the injured area.

The process is tightly controlled, and it causes harm when it goes wrong. Dysregulated vessel growth contributes to cancers, ischemic disease, and inflammatory, infectious and immune disorders. Thymosin beta-4, a naturally occurring peptide, regulates angiogenesis and has roles in both wound healing and tumor progression, which shows the same signal can serve repair or disease.

Why it matters

Angiogenesis is the mechanism most often cited for BPC-157 and TB-500, and the data are mostly preclinical. In animal and cell studies, BPC-157 activates VEGFR2 and nitric oxide production through the Akt-eNOS pathway, which promotes new vessel growth, particularly in tissues with poor blood supply such as tendons. Human data are extremely limited: a 2025 review found only three small pilot studies, covering knee pain injections, interstitial cystitis, and intravenous safety and pharmacokinetics. The reviewers described the preclinical support as broad, concluded that BPC-157 should be considered investigational, and called for well-designed human trials. The thymosin beta-4 angiogenesis research is on the natural peptide; research-market TB-500 is sold as a related product, so those findings may not transfer to what is in a given vial.

The same process that feeds a healing tendon can feed a tumor. A compound that genuinely promotes vessel growth carries a theoretical concern for anyone with an existing cancer, and that question has not been studied in people for these peptides.

How to read an angiogenesis claim

  1. Check the model: cells in a dish, rodents, or people.
  2. Check the marker: VEGF or VEGFR2 signaling, capillary density in tissue, or vessel-like tube formation in culture.
  3. Check whether a functional outcome improved, such as tendon strength or healing time, not just a vessel count.
  4. Look for human data and how many people were studied.
  5. Look for any safety data in people with a history of cancer.

Common mistakes

  • Assuming that more new vessels in a rat means faster healing in a person.
  • Treating research-market TB-500 as identical to the thymosin beta-4 used in published studies.
  • Ignoring that tumors depend on the same vessel-growth signals.
  • Reading "no adverse effects reported" in three small pilot studies as proof of safety.
  • Equating tube formation in a dish with tissue repair.
  • Assuming that because a peptide is popular with athletes it has been tested in athletes; the human data remain minimal.

Sources

  1. ReviewAngiogenesis in health and disease. Nat Med, 2003. PMID 12778163.
  2. ReviewRegeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med, 2025. PMID 40789979.
  3. ReviewThymosin beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis, 2007. PMID 17632766.

Page updated . How we grade evidence: methodology.

Related Terms

Healing Peptide

'Healing peptide' is an informal label for peptides promoted for tissue repair, such as BPC-157 and TB-500; their evidence comes mostly from animal studies.

Stack

A stack is two or more compounds used during the same period, usually chosen because they are thought to act through different mechanisms on the same goal.

Cytokine Modulation

Cytokine modulation is changing the levels or effects of cytokines, the small signaling proteins that start, steer and end inflammation.

Look up any peptide term inside DoseCraft Pro

The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.

Start Free Trial